FR2002067A1 - Esters de alpha-alkyl-5-hydroxytryptophane,leur production et des compositions en contenant - Google Patents

Esters de alpha-alkyl-5-hydroxytryptophane,leur production et des compositions en contenant

Info

Publication number
FR2002067A1
FR2002067A1 FR6903745A FR6903745A FR2002067A1 FR 2002067 A1 FR2002067 A1 FR 2002067A1 FR 6903745 A FR6903745 A FR 6903745A FR 6903745 A FR6903745 A FR 6903745A FR 2002067 A1 FR2002067 A1 FR 2002067A1
Authority
FR
France
Prior art keywords
alkyl
tranquillers
hydroxytryptophane
hypotensives
antihypertensives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6903745A
Other languages
English (en)
Inventor
Voorhees Heinzelman Richard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2002067A1 publication Critical patent/FR2002067A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/51—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
FR6903745A 1968-02-16 1969-02-14 Esters de alpha-alkyl-5-hydroxytryptophane,leur production et des compositions en contenant Withdrawn FR2002067A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70592268A 1968-02-16 1968-02-16

Publications (1)

Publication Number Publication Date
FR2002067A1 true FR2002067A1 (fr) 1969-10-03

Family

ID=24835493

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6903745A Withdrawn FR2002067A1 (fr) 1968-02-16 1969-02-14 Esters de alpha-alkyl-5-hydroxytryptophane,leur production et des compositions en contenant

Country Status (6)

Country Link
BE (1) BE728421A (fr)
DE (1) DE1906322A1 (fr)
ES (1) ES363559A1 (fr)
FR (1) FR2002067A1 (fr)
GB (1) GB1184538A (fr)
NL (1) NL6902421A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378759A1 (fr) * 1976-06-22 1978-08-25 Hoffmann La Roche Procede pour la preparation de composes de derives d'indole
US4256641A (en) 1976-06-22 1981-03-17 Hoffmann-La Roche Inc. Novel syntheses of tryptophans
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472978A (en) * 1991-07-05 1995-12-05 Merck Sharp & Dohme Ltd. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
US5328927A (en) * 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
EP2098524A1 (fr) * 2008-03-05 2009-09-09 4Sc Ag Procédé pour la préparation d'indolopyrinidines énantiomériquement pures

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378759A1 (fr) * 1976-06-22 1978-08-25 Hoffmann La Roche Procede pour la preparation de composes de derives d'indole
US4256641A (en) 1976-06-22 1981-03-17 Hoffmann-La Roche Inc. Novel syntheses of tryptophans
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines

Also Published As

Publication number Publication date
BE728421A (fr) 1969-08-14
ES363559A1 (es) 1971-01-01
DE1906322A1 (de) 1969-09-25
GB1184538A (en) 1970-03-18
NL6902421A (fr) 1969-08-19

Similar Documents

Publication Publication Date Title
DK0738270T3 (da) Dihydropyrazolopyrroler
AR024732A1 (es) Metodo para el tratamiento del dolor cronico mediante la utilizacion de inhibidores mek.
MY131501A (en) Process for the prepration of clavulanic acid
DE69411900D1 (de) Heterozyklische derivate als plätchenaggregationsinhibitoren
AR247732A1 (es) Procedimiento para obtener amidas de acido piridin-2, 4- y -2, 5-dicarboxilico
FR2002067A1 (fr) Esters de alpha-alkyl-5-hydroxytryptophane,leur production et des compositions en contenant
SE9300758L (sv) Förfarande för framställning av kavulansyrasalter
ES347430A1 (es) Procedimiento para la obtencion de derivados de benzoxazi- na.
ES2083972T3 (es) Arilalquil-aminas y -amidas con propiedades anticonvulsivas y neuroprotectoras.
TR199800813T2 (xx) Nitrik oksit sintaz�n�n �nleyicileri olarak amidin, isot�re t�revleri.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
CA921051A (en) Basic substituted amides of n-substituted anthranilic acids and their salts and method of producing said compounds
ES367846A1 (es) Procedimiento para la produccion de compuestos de pirazolo-diazepinona.
GB1126352A (en) Isoquinolinobenzodiazepine derivatives
GB1353486A (en) Benzodiazepine derivatives
GB1332766A (en) Triazolo-benzodiazepines
ES361664A1 (es) Procedimiento para la preparacion de nuevo acido antrani- lico.
ATE180766T1 (de) Diester von carbonsäure mit antiviraler und anti- entzündungsaktivität
NZ309498A (en) 2-substituted benzyl-benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
SE7903042L (sv) Sett att framstella n-(polysackaridyl)-kveve-heterocykler, isynnerhet av pyrimidin- eller pyrinbaser
GB1381249A (en) Isoxazolidine derivatives
GB1307390A (en) Benzodioxanes
GB1246127A (en) Bis-piperazinyl compounds
IT1247034B (it) Acidi dimetilamino-idrossi alchil difosfonici e loro sali, loro procedimento produttivo e composizioni farmaceutiche che li comprendono
SU760673A1 (ru) Гидрохлорид бензойного эфира 1-аллил-2,5-диметил-5-метоксипиперидола-4, проявляющий анальгетическую, противовоспалительную и бактериостатическую активность

Legal Events

Date Code Title Description
RE Withdrawal of published application